Le Lézard
Classified in: Health, Science and technology, Business
Subjects: ERN, ERP

Veeva Announces Fiscal 2023 Second Quarter Results


Total Revenues of $534.2M, up 17% Year Over Year; Subscription Services Revenues of $428.6M, up 17% Year Over Year

PLEASANTON, Calif., Aug. 31, 2022 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its second quarter ended July 31, 2022.

"Our innovation engine is delivering more value to our customers than ever as we continue making progress with established and newly launched products in commercial and R&D," said CEO Peter Gassner. "We are early in a large and growing opportunity and look forward to expanding our position as the strategic technology partner to the life sciences industry across their most critical functions."

Fiscal 2023 Second Quarter Results:

"Veeva's durable business model delivered another quarter of solid revenue growth and strong profitability," said CFO Brent Bowman. "We are very confident in our competitive position and we are performing well financially as we track ahead of our 2025 targets."

Recent Highlights:
Financial Outlook:

Veeva is providing guidance for its fiscal third quarter ending October 31, 2022 as follows:

Veeva is providing updated guidance for its fiscal year ending January 31, 2023 as follows:

Conference Call Information

Prepared remarks and an investor presentation providing additional information and analysis can be found on Veeva's investor relations website at ir.veeva.com. Veeva will host a Q&A conference call at 2:00 p.m. PT today, August 31, 2022, and a replay of the call will be available on Veeva's investor relations website.

What:

Veeva Systems Fiscal 2023 Second Quarter Results Conference Call

When:

Wednesday, August 31, 2022

Time:

2:00 p.m. PT (5:00 p.m. ET)

Online Registration:

https://conferencingportals.com/event/badXudFz



Webcast:

ir.veeva.com








(1)

This press release uses non-GAAP financial metrics that are adjusted for the impact of various GAAP items. See the section titled "Non-GAAP Financial Measures" and the tables entitled "Reconciliation of GAAP to Non-GAAP Financial Measures" below for details.



(2)

Veeva is not able, at this time, to provide GAAP targets for operating income and fully diluted net income per share for the third fiscal quarter ending October 31, 2022 or fiscal year ending January 31, 2023 because of the difficulty of estimating certain items excluded from non-GAAP operating income and non-GAAP fully diluted net income per share that cannot be reasonably predicted, such as charges related to stock-based compensation expense and amortization of purchased intangibles. The effect of these excluded items may be significant.

About Veeva Systems

Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders and the industries it serves. For more information, visit veeva.com.

Veeva uses its ir.veeva.com website as a means of disclosing material non-public information, announcing upcoming investor conferences, and for complying with its disclosure obligations under Regulation FD. Accordingly, you should monitor our investor relations website in addition to following our press releases, SEC filings, and public conference calls and webcasts.

Forward-looking Statements

This release contains forward-looking statements regarding Veeva's expected future performance and, in particular, includes quotes from management and guidance provided as of August 31, 2022 about Veeva's expected future financial results. Estimating guidance accurately for future periods is difficult. It involves assumptions and internal estimates that may prove to be incorrect and is based on plans that may change. Hence, there is a significant risk that actual results could differ materially from the guidance we have provided in this release and we have no obligation to update such guidance. There are also numerous risks that have the potential to negatively impact our financial performance, including as a result of competitive factors, customer decisions and priorities, events that impact the life sciences industry, issues related to the security or performance of our products, the pandemic, issues that impact our ability to hire, retain and adequately compensate talented employees, fluctuations in foreign currency exchange rates, and general macroeconomic and geopolitical events (including inflationary pressures and impacts related to Russia's invasion of Ukraine). We have summarized what we believe are the principal risks to our business in a section titled "Summary of Risk Factors" on pages 37 and 38 in our filing on Form 10-Q for the period ended April 30, 2022 which you can find here. Additional details on the risks and uncertainties that may impact our business can be found in the same filing on Form 10-Q and in our subsequent SEC filings, which you can access at sec.gov. We recommend that you familiarize yourself with these risks and uncertainties before making an investment decision.

Investor Relations Contact:
Ato Garrett
Veeva Systems Inc.
925-271-4204
[email protected]

Media Contact:
Maria Scurry
Veeva Systems Inc.
781-366-7617
[email protected]

 

VEEVA SYSTEMS INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)



July 31,
2022


January 31,
2022

Assets




Current assets:




Cash and cash equivalents

$      1,140,246


$      1,138,040

Short-term investments

1,778,861


1,238,064

Accounts receivable, net

313,219


631,134

Unbilled accounts receivable

77,778


63,266

Prepaid expenses and other current assets

46,038


36,679

Total current assets

3,356,142


3,107,183

Property and equipment, net

52,409


54,495

Deferred costs, net

27,877


33,106

Lease right-of-use assets

58,539


49,640

Goodwill

439,877


439,877

Intangible assets, net

92,288


101,940

Deferred income taxes

62,059


5,097

Other long-term assets

27,392


25,127

Total assets

$      4,116,583


$      3,816,465





Liabilities and stockholders' equity




Current liabilities:




Accounts payable

$           30,915


$           20,348

Accrued compensation and benefits

36,609


33,834

Accrued expenses and other current liabilities

30,714


36,109

Income tax payable

5,143


7,761

Deferred revenue

684,642


731,746

Lease liabilities

11,366


10,981

Total current liabilities

799,389


840,779

Deferred income taxes

1,657


2,216

Lease liabilities, noncurrent

52,106


43,607

Other long-term liabilities

19,500


18,226

Total liabilities

872,652


904,828

Stockholders' equity:




Class A common stock

2


2

Class B common stock

?


?

Additional paid-in capital

1,353,502


1,196,547

Accumulated other comprehensive loss

(27,335)


(11,958)

Retained earnings

1,917,762


1,727,046

Total stockholders' equity

3,243,931


2,911,637

Total liabilities and stockholders' equity

$      4,116,583


$      3,816,465

 

VEEVA SYSTEMS INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands, except per share data)
(Unaudited)



Three months ended
July 31,


Six months ended
July 31,


2022


2021


2022


2021

Revenues:








Subscription services(3)

$ 428,649


$ 366,436


$ 831,281


$  707,555

Professional services and other(4)

105,569


89,158


208,039


181,612

Total revenues

534,218


455,594


1,039,320


889,167

Cost of revenues(5):








Cost of subscription services

64,035


53,909


122,988


105,126

Cost of professional services and other

87,634


68,188


168,196


133,107

Total cost of revenues

151,669


122,097


291,184


238,233

Gross profit

382,549


333,497


748,136


650,934

Operating expenses(5):








Research and development

134,008


94,899


247,483


178,125

Sales and marketing

89,617


71,789


165,732


136,399

General and administrative

57,832


42,185


106,157


83,340

Total operating expenses

281,457


208,873


519,372


397,864

Operating income

101,092


124,624


228,764


253,070

Other income, net

8,398


1,666


11,107


6,230

Income before income taxes

109,490


126,290


239,871


259,300

Provision for income taxes

18,889


17,432


49,155


34,875

Net income

$   90,601


$ 108,858


$ 190,716


$  224,425

Net income per share:








Basic

$       0.58


$       0.71


$       1.23


$       1.47

Diluted

$       0.56


$       0.67


$       1.17


$       1.38

Weighted-average shares used to compute net income per share:








Basic

154,951


153,090


154,736


152,768

Diluted

162,132


162,765


162,499


162,636

Other comprehensive income:








Net change in unrealized loss on available-for-sale investments

$    (2,224)


$       (217)


$  (13,223)


$    (1,303)

Net change in cumulative foreign currency translation loss

(900)


(165)


(2,154)


(2,378)

Comprehensive income

$   87,477


$ 108,476


$ 175,339


$  220,744









(3) Includes subscription services revenues from the following product areas:








Veeva Commercial Solutions(6)

$ 236,356


$ 218,128


$ 464,080


$  425,973

Veeva R&D Solutions(6)

192,293


148,308


367,201


281,582

Total subscription services

$ 428,649


$ 366,436


$ 831,281


$  707,555









(4) Includes professional services and other revenues from the following product areas:








Veeva Commercial Solutions(6)

$   44,424


$   38,968


$   87,745


$   82,567

Veeva R&D Solutions(6)

61,145


50,190


120,294


99,045

Total professional services and other

$ 105,569


$   89,158


$ 208,039


$  181,612

(6) Certain prior period revenues have been adjusted to match current period presentation.









(5) Includes stock-based compensation as follows:








Cost of revenues:








Cost of subscription services

1,693


1,316


$     2,970


2,222

Cost of professional services and other

13,818


9,541


$   23,808


16,963

Research and development

38,901


22,315


64,724


39,152

Sales and marketing

24,031


15,115


40,924


26,670

General and administrative

17,599


14,098


30,750


25,867

Total stock-based compensation

$   96,042


$   62,385


$ 163,176


$  110,874

 

VEEVA SYSTEMS INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)



Three months ended
July 31,


Six months ended
July 31,


2022


2021


2022


2021

Cash flows from operating activities








Net income

$       90,601


$     108,858


$     190,716


$     224,425

Adjustments to reconcile net income to net cash provided by operating activities:








Depreciation and amortization

7,228


6,880


14,286


13,508

Reduction of operating lease right-of-use assets

3,020


2,874


5,968


5,701

(Accretion) amortization of discount on short-term investments

(507)


1,743


549


3,285

Stock-based compensation

96,042


62,385


163,176


110,874

Amortization of deferred costs

5,736


6,474


11,729


12,829

Deferred income taxes

(20,881)


6,953


(53,313)


12,195

 Loss on foreign currency from mark-to-market derivative

1,768


2


1,186


433

Bad debt (recovery) expense

146


(22)


121


137

Changes in operating assets and liabilities:








Accounts receivable

16,312


(21,409)


317,794


280,323

Unbilled accounts receivable

(15,807)


267


(14,512)


(3,894)

Deferred costs

(3,421)


(3,802)


(6,500)


(8,092)

Other current and long-term assets

(3,513)


(3,866)


(11,076)


(1,129)

Accounts payable

5,540


5,031


10,661


(1,763)

Accrued expenses and other current liabilities

(475)


2,216


(2,811)


9,183

Income taxes payable

(45,841)


(3,726)


(2,618)


(17)

Deferred revenue

(39,998)


(49,783)


(47,469)


(57,959)

Operating lease liabilities

(3,081)


(2,913)


(5,112)


(5,661)

Other long-term liabilities

517


903


1,638


3,072

Net cash provided by operating activities

93,386


119,065


574,413


597,450

Cash flows from investing activities








Purchases of short-term investments

(433,073)


(422,680)


(1,005,417)


(679,618)

Maturities and sales of short-term investments

250,531


187,324


446,721


408,969

Acquisitions, net of cash and restricted cash acquired

?


(2,133)


?


(2,133)

Long-term assets

(1,663)


(5,325)


(3,996)


(7,981)

Net cash used in investing activities

(184,205)


(242,814)


(562,692)


(280,763)

Cash flows from financing activities








Changes in lease liabilities - finance leases

?


(98)


?


(384)

Proceeds from exercise of common stock options

9,250


20,851


25,541


37,942

Taxes paid related to net share settlement of equity awards

(17,134)


(15,096)


(32,133)


(15,096)

Net cash (used in) provided by financing activities

(7,884)


5,657


(6,592)


22,462

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

(1,049)


(180)


(2,923)


(2,945)

Net change in cash, cash equivalents, and restricted cash

(99,752)


(118,272)


2,206


336,204

Cash, cash equivalents, and restricted cash at beginning of period

1,243,183


1,186,188


1,141,225


731,712

Cash, cash equivalents, and restricted cash at end of period

$  1,143,431


$  1,067,916


$  1,143,431


$  1,067,916









Supplemental disclosures of other cash flow information:








Excess tax benefits from employee stock plans

$         2,094


$       17,609


$         5,093


$       35,060

 

Non-GAAP Financial Measures

In Veeva's public disclosures, Veeva has provided non-GAAP measures, which it defines as financial information that has not been prepared in accordance with generally accepted accounting principles in the United States, or GAAP. In addition to its GAAP measures, Veeva uses these non-GAAP financial measures internally for budgeting and resource allocation purposes and in analyzing its financial results. For the reasons set forth below, Veeva believes that excluding the following items provides information that is helpful in understanding its operating results, evaluating its future prospects, comparing its financial results across accounting periods, and comparing its financial results to its peers, many of which provide similar non-GAAP financial measures.

There are limitations to using non-GAAP financial measures because non-GAAP financial measures are not prepared in accordance with GAAP and may be different from non-GAAP financial measures provided by other companies. The non-GAAP financial measures are limited in value because they exclude certain items that may have a material impact upon our reported financial results. In addition, they are subject to inherent limitations as they reflect the exercise of judgments by Veeva's management about which items are adjusted to calculate its non-GAAP financial measures. Veeva compensates for these limitations by analyzing current and future results on a GAAP basis as well as a non-GAAP basis and also by providing GAAP measures in its public disclosures.

Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Veeva encourages its investors and others to review its financial information in its entirety, not to rely on any single financial measure to evaluate its business, and to view its non-GAAP financial measures in conjunction with the most directly comparable GAAP financial measures. A reconciliation of GAAP to the non-GAAP financial measures has been provided in the tables below.

The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below:

 

Reconciliation of Net Cash Provided by Operating Activities (GAAP basis to non-GAAP basis)

Three months ended
July 31,


Six months ended
July 31,



2022


2021


2022


2021


Net cash provided by operating activities

$ 93,386


$ 119,065


574,413


$ 597,450


Excess tax benefits from employee stock plans

(2,094)


(17,609)


(5,093)


(35,060)


Impact of tax legislation

37,946


?


37,946


?


Net cash provided by operating activities on a non-GAAP basis

$ 129,238


$ 101,456


$ 607,266


$ 562,390


Net cash used in investing activities

$ (184,205)


$ (242,814)


$ (562,692)


$ (280,763)


Net cash (used in) provided by financing activities

$  (7,884)


$ 5,657


$ (6,592)


$ 22,462











Reconciliation of Financial Measures (GAAP basis to non-GAAP basis)

Three months ended
July 31,


Six months ended
July 31,



2022


2021


2022


2021


Cost of subscription services revenues on a GAAP basis

$ 64,035


$ 53,909


$ 122,988


$ 105,126


Stock-based compensation expense

(1,693)


(1,316)


(2,970)


(2,222)


Amortization of purchased intangibles

(1,126)


(925)


(2,216)


(1,821)


Cost of subscription services revenues on a non-GAAP basis

$ 61,216


$ 51,668


$ 117,802


$ 101,083











Gross margin on subscription services revenues on a GAAP basis

85.1 %


85.3 %


85.2 %


85.1 %


Stock-based compensation expense

0.4


0.4


0.3


0.3


Amortization of purchased intangibles

0.2


0.2


0.3


0.3


Gross margin on subscription services revenues on a non-GAAP basis

85.7 %


85.9 %


85.8 %


85.7 %











Cost of professional services and other revenues on a GAAP basis

$ 87,634


$ 68,188


$ 168,196


$ 133,107


Stock-based compensation expense

(13,818)


(9,541)


(23,808)


(16,963)


Amortization of purchased intangibles

(139)


(139)


(273)


(273)


Cost of professional services and other revenues on a non-GAAP basis

$ 73,677


$ 58,508


$ 144,115


$ 115,871











Gross margin on professional services and other revenues on a GAAP basis

17.0 %


23.5 %


19.2 %


26.7 %


Stock-based compensation expense

13.1


10.7


11.4


9.3


Amortization of purchased intangibles

0.1


0.2


0.1


0.2


Gross margin on professional services and other revenues on a non-GAAP basis

30.2 %


34.4 %


30.7 %


36.2 %











Gross profit on a GAAP basis

$ 382,549


$ 333,497


$ 748,136


$ 650,934


Stock-based compensation expense

15,511


10,857


26,778


19,185


Amortization of purchased intangibles

1,265


1,064


2,489


2,094


Gross profit on a non-GAAP basis

$ 399,325


$ 345,418


$ 777,403


$ 672,213











Gross margin on total revenues on a GAAP basis

71.6 %


73.2 %


72.0 %


73.2 %


Stock-based compensation expense

2.9


2.4


2.6


2.2


Amortization of purchased intangibles

0.2


0.2


0.2


0.2


Gross margin on total revenues on a non-GAAP basis

74.7 %


75.8 %


74.8 %


75.6 %











Research and development expense on a GAAP basis

$ 134,008


$ 94,899


$ 247,483


$ 178,125


Stock-based compensation expense

(38,901)


(22,315)


(64,724)


(39,152)


Amortization of purchased intangibles

(29)


(29)


(56)


(56)


Research and development expense on a non-GAAP basis

$ 95,078


$ 72,555


$ 182,703


$ 138,917





















Three months ended
July 31,


Six months ended
July 31,



2022


2021


2022


2021











Sales and marketing expense on a GAAP basis

$ 89,617


$ 71,789


$ 165,732


$ 136,399


Stock-based compensation expense

(24,031)


(15,115)


(40,924)


(26,670)


Amortization of purchased intangibles

(3,555)


(3,429)


(6,995)


(6,745)


Sales and marketing expense on a non-GAAP basis

$ 62,031


$ 53,245


$ 117,813


$ 102,984











General and administrative expense on a GAAP basis

$ 57,832


$ 42,185


$ 106,157


$ 83,340


Stock-based compensation expense

(17,599)


(14,098)


(30,750)


(25,867)


Amortization of purchased intangibles

(57)


(57)


(112)


(112)


General and administrative expense on a non-GAAP basis

$ 40,176


$ 28,030


$ 75,295


$ 57,361











Operating expense on a GAAP basis

$ 281,457


$ 208,873


$ 519,372


$  397,864


Stock-based compensation expense

(80,531)


(51,528)


(136,398)


(91,689)


Amortization of purchased intangibles

(3,641)


(3,515)


(7,163)


(6,913)


Operating expense on a non-GAAP basis

$ 197,285


$ 153,830


$ 375,811


$ 299,262











Operating income on a GAAP basis

$ 101,092


$ 124,624


$ 228,764


$ 253,070


Stock-based compensation expense

96,042


62,385


163,176


110,874


Amortization of purchased intangibles

4,906


4,579


9,652


9,007


Operating income on a non-GAAP basis

$ 202,040


$ 191,588


$ 401,592


$ 372,951











Operating margin on a GAAP basis

18.9 %


27.4 %


22.0 %


28.5 %


Stock-based compensation expense

18.0


13.7


15.7


12.5


Amortization of purchased intangibles

0.9


1.0


0.9


1.0


Operating margin on a non-GAAP basis

37.8 %


42.1 %


38.6 %


42.0 %











Net income on a GAAP basis

$ 90,601


$ 108,858


$ 190,716


$ 224,425


Stock-based compensation expense

96,042


62,385


163,176


110,874


Amortization of purchased intangibles

4,906


4,579


9,652


9,007


Income tax effect on non-GAAP adjustments(7)

(25,303)


(23,151)


(37,512)


(44,753)


Net income on a non-GAAP basis

$ 166,246


$ 152,671


$  326,032


$ 299,553











Diluted net income per share on a GAAP basis

$     0.56


$     0.67


$     1.17


$     1.38


Stock-based compensation expense

0.59


0.38


1.00


0.68


Amortization of purchased intangibles

0.03


0.03


0.06


0.06


Income tax effect on non-GAAP adjustments(7)

(0.15)


(0.14)


(0.22)


(0.28)


Diluted net income per share on a non-GAAP basis

$     1.03


$     0.94


$     2.01


$     1.84




(7)   

For the three and six months July 31, 2022 and 2021, management used an estimated annual effective non-GAAP tax rate of 21.0%.

 

SOURCE Veeva Systems


These press releases may also interest you

at 16:10
Clearwater Paper Corporation will release its fourth quarter and full year 2022 results on Tuesday, February 14, 2023. President and Chief Executive Officer, Arsen Kitch and Senior Vice President of Finance and Chief Financial Officer, Mike Murphy...

at 16:10
Alight today announced it will release fourth quarter and full year 2022 earnings results after the market close on Tuesday, February 21, 2023, and management will discuss the results on a conference call at 5 pm ET the same day. The webcast and a...

at 16:10
GoodRx Holdings Inc. , a leading digital healthcare platform, today announced it will release its fourth quarter and full year 2022 financial results after U.S. markets close on Tuesday, February 28, 2023. GoodRx management will also hold a...

at 16:10
Varex Imaging Corporation today announced its unaudited financial results for the first quarter of fiscal year 2023. 1QFY23 Summary Revenues $206 million GAAP gross margin 31% | Non-GAAP gross margin* 32% GAAP operating expense $50 million |...

at 16:10
ON24 will release its fourth quarter and full year 2022 financial results after U.S. markets close on Tuesday, February 28, 2023. ON24 management will host a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to...

at 16:10
Bruker Corporation today announced it will report fourth quarter and fiscal year 2022 financial results before market opening on Thursday, February 9, 2023. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to...



News published on 31 august 2022 at 16:05 and distributed by: